Yazar "Koyutürk, Meral" için listeleme
-
Comparative analysis of effects of conditioned mediums obtained from 2D or 3D cultured mesenchymal stem cells on kidney functions of diabetic rats: Early intervention could potentiate transdifferentiation of parietal epithelial cell into podocyte precursors
Özkan, Serbay; Işıldar, Başak; Şahin, Hakan; Saygı, Halil İbrahim; Konukoğlu, Dildar; Koyutürk, Meral (Elsevier, 2024)Aim: The secretome of mesenchymal stem cells (MSCs) could be a potential therapeutic intervention for diabetes and associated complications like nephropathy. This study aims to evaluate the effects of conditioned ... -
Effects of conditioned mediums collected from 2d or 3d cultured mscs on kidney functions of rats with autoimmune diabetes induced with streptozocin
Özkan, Serbay; Işıldar, Başak; Şahin, Hakan; Saygı, Halil İbrahim; Konukoğlu, Dildar; Koyutürk, Meral (Oxford Univ Press, 2023)Background and Aims: The main mechanism of therapeutic action of mesenchymal stem cells (MSCs) could be resulted from their secretome content rather than their direct differentiation into damaged cells [1, 2]. Preconditioning ... -
Preconditioning of human umbilical cord mesenchymal stem cells with a histone deacetylase inhibitor: Valproic acid
Işıldar, Başak; Özkan, Serbay; Koyutürk, Meral (Galenos Publishing House, 2024)Background: Mesenchymal stem cells (MSCs) play a key role in regenerative medicine due to their capacity to differentiate into multiple cell lines, regulate the immune system, and exert paracrine effects. The therapeutic ... -
Preconditioning of human umbilical cord mesenchymal stem cells with deferoxamine potentiates the capacity of the secretome released from the cells and promotes immunomodulation and beta cell regeneration in a rat model of type 1 diabetes
Işıldar, Başak; Özkan, Serbay; Şahin, Hakan; Erçin, Merve; Oktayoğlu, Selda Gezginci; Koyutürk, Meral (Elsevier, 2024)This study aimed to examine the effects of the secretome released by human umbilical cord-mesenchymal stem cells (MSC) as a result of preconditioning with deferoxamine (DFX), a hypoxia mimetic agent, on type 1 diabetes ... -
Therapeutic potential of mesenchymal stem cell-derived conditioned medium for diabetes mellitus and related complications
Işıldar, Başak; Özkan, Serbay; Koyutürk, Meral (Wiley, 2023)Diabetes mellitus (DM) is one of the most life-threatening metabolic disorders, with 9% of the global prevalence, and it is estimated to be rising to 12.2% in 2045. Currently, there is no definitive treatment for DM. ...
